Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies

Title
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies
Authors
Keywords
-
Journal
Journal of Managed Care & Specialty Pharmacy
Volume 29, Issue 10, Pages 1119-1128
Publisher
Academy of Managed Care Pharmacy
Online
2023-09-30
DOI
10.18553/jmcp.2023.29.10.1119

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started